With reference to the newly FDA-approved drug Cobenfy for schizophrenia, consider the following statements:

1. Cobenfy is the first antipsychotic drug that targets cholinergic receptors instead of dopamine receptors.

2. Cobenfy is composed of xanomeline and trospium chloride, which work together to reduce side effects and improve treatment outcomes.

3. Schizophrenia is equally prevalent among both sexes, typically developing during late adolescence and early adulthood.

Which of the statements given above is/are correct?